DnB Asset Management
MIRM icon

DnB Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

DnB Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
+2,036
New +$204K ﹤0.01% 1115

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DnB Asset Management's MIRM Position: Q2 2026 in Review

DnB Asset Management opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 2,036 shares worth $238K. The stake represents ﹤0.01% of the portfolio and ranks #1115 among its holdings.

327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • DnB Asset Management held 2,036 shares of Mirum Pharmaceuticals worth $238K as of Q2 2026.
  • Mirum Pharmaceuticals was a new DnB Asset Management position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of DnB Asset Management's portfolio in Q2 2026, its #1115 holding.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.